McKesson OneStop Generics® Program definition
McKesson OneStop Generics® Program has the meaning set forth in the definition of OneStop Program. “[***]” means [***]. “[***]” has the meaning set forth in [***].
McKesson OneStop Generics® Program has the meaning set forth in the definition of OneStop Program. “[***]” means [***]. “[***]” has the meaning set forth in [***]. “Non-Qualifying Retail Facilities” shall mean all Retail Omnicare Facilities [***]. “Omnicare Facilities” has the meaning set forth in Section 2.2. "[***]" means [***]. “OneStop Program” means the proprietary McKesson OneStop Generics® program (“McKesson OneStop Generics® Program”), including the auto-substitution feature, available to Omnicare pursuant to this Agreement. For purposes of this Agreement, [***] (as described in Section [***]) are [***]. “Pharmaceutical Products” means [***]. “Prime Vendor” means that MHS shall be the first choice for the purchase of all Pharmaceutical Products normally purchased through wholesale pharmaceutical distributors. “Prime Vendor Commitment” has the meaning set forth in Section 2.1. “Products” means collectively Pharmaceutical Products, Additional Products and any and all of the pharmaceutical products and related healthcare products available for sale from MHS. “Purchase Commitment Failure” has the meaning set forth in Section 2.1.2. “Qualifying Retail Facilities” means, with respect to [***], all Retail Omnicare Facilities (other than [***]), provided that the following requirements are met: [***]. “Retail” means Omnicare Facilities which principally dispense medications to patients on a walk-in basis, rather than through medication delivery. In no event shall an Omnicare Facility which principally dispenses medications via medication delivery (e.g., LTC) or the mail (e.g., specialty) be deemed “Retail” hereunder as a consequence of such Omnicare Facility dispensing a small proportion of its medications to walk-in customers. “Service Level” has the meaning set forth in Section 6. “Slow Moving Product” means Product that is [***] by sales volume of its therapeutic class (as defined by First DataBank) and which either has a therapeutic equivalent listed in the FDA Orange Book (i.e., a Generic equivalent) with the same strength, dosage and presentation (e.g., tablets, capsules or suspension) available from McKesson or has another package size of the given strength, dosage and presentation from the same manufacturer available from McKesson. “[***]” has the meaning set forth in Section [***]. “[***]” has the meaning set forth in Section [***]. EXECUTION COPY 29 PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES ...